Patient-reported outcomes (PROs) are pivotal in advancing renal replacement therapies and guiding patient-centered care. Recent findings from the CONVINCE trial demonstrate the superiority of high-volume hemodiafiltration, which improves life expectancy, slows the decline in physical and cognitive function, and enhance participation in social activities, compared to standard hemodialysis.
#NephrologyCampus